受强制性开放获取政策约束的文章 - Malik Juweid了解详情
可在其他位置公开访问的文章：10 篇
AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development
SN Khleif, JH Doroshow, WN Hait
Clinical Cancer Research 16 (13), 3299-3318, 2010
强制性开放获取政策： US National Institutes of Health
Molecular imaging of proliferation in malignant lymphoma
AK Buck, M Bommer, S Stilgenbauer, M Juweid, G Glatting, ...
Cancer research 66 (22), 11055-11061, 2006
强制性开放获取政策： German Research Foundation
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study
SJ Horning, ME Juweid, H Schöder, G Wiseman, A McMillan, LJ Swinnen, ...
Blood, The Journal of the American Society of Hematology 115 (4), 775-777, 2010
强制性开放获取政策： US National Institutes of Health
Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine
AK Buck, K Herrmann, CM Büschenfelde, ME Juweid, M Bischoff, ...
Clinical cancer research 14 (10), 2970-2977, 2008
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET
DJ Straus, JL Johnson, AS LaCasce, NL Bartlett, L Kostakoglu, ED Hsi, ...
Blood, The Journal of the American Society of Hematology 117 (20), 5314-5320, 2011
强制性开放获取政策： US National Institutes of Health
Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT
AK Buck, C Kratochwil, G Glatting, M Juweid, M Bommer, D Tepsic, ...
European journal of nuclear medicine and molecular imaging 34, 1775-1782, 2007
强制性开放获取政策： German Research Foundation
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine
AK Buck, M Bommer, ME Juweid, G Glatting, S Stilgenbauer, FM Mottaghy, ...
Journal of Nuclear Medicine 49 (11), 1756-1762, 2008
强制性开放获取政策： German Research Foundation
Diffuse large B-cell lymphoma: prospective multicenter comparison of early interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST criteria for early …
R Minamimoto, L Fayad, R Advani, J Vose, H Macapinlac, J Meza, ...
Radiology 280 (1), 220-229, 2016
强制性开放获取政策： US National Institutes of Health
18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study
R Minamimoto, L Fayad, J Vose, J Meza, R Advani, J Hankins, F Mottaghy, ...
European journal of nuclear medicine and molecular imaging 48 (9), 2883-2893, 2021
强制性开放获取政策： US National Institutes of Health
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
CR Stork
强制性开放获取政策： German Research Foundation
出版信息和资助信息由计算机程序自动确定